Changes in immunosuppressive treatment of chronic graft-versus-host disease: comparison of 2 surveys within allogeneic hematopoietic stem cell transplant centers in Germany, Austria, and Switzerland
Chronic graft-versus-host disease (cGVHD) remains the leading cause of late morbidity and mortality. Despite the growing number of treatment options in cGVHD, evidence remains sparse. The German-Austrian-Swiss GVHD Consortium performed a survey on clinical practice in treatment of cGVHD among transp...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2019
|
| In: |
Biology of blood and marrow transplantation
Year: 2019, Volume: 25, Issue: 7, Pages: 1450-1455 |
| ISSN: | 1523-6536 |
| DOI: | 10.1016/j.bbmt.2019.03.003 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1016/j.bbmt.2019.03.003 Verlag: http://www.sciencedirect.com/science/article/pii/S1083879119301545 
|
| Author Notes: | Daniel Wolff, Inken Hilgendorf, Eva Wagner-Drouet, Zuzana Jedlickova, Francis Ayuk, Robert Zeiser, Kerstin Schäfer-Eckart, Armin Gerbitz, Michael Stadler, Stefan Klein, Jan-Moritz Middeke, Anita Lawitschka, Julia Winkler, Jörg Halter, Ernst Holler, Guido Kobbe, Matthias Stelljes, Markus Ditschkowski, Hildegard Greinix |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1684667844 | ||
| 003 | DE-627 | ||
| 005 | 20220817175214.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191206s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bbmt.2019.03.003 |2 doi | |
| 035 | |a (DE-627)1684667844 | ||
| 035 | |a (DE-599)KXP1684667844 | ||
| 035 | |a (OCoLC)1341280485 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wolff, Daniel |d 1967- |e VerfasserIn |0 (DE-588)120201275 |0 (DE-627)080517838 |0 (DE-576)292092881 |4 aut | |
| 245 | 1 | 0 | |a Changes in immunosuppressive treatment of chronic graft-versus-host disease |b comparison of 2 surveys within allogeneic hematopoietic stem cell transplant centers in Germany, Austria, and Switzerland |c Daniel Wolff, Inken Hilgendorf, Eva Wagner-Drouet, Zuzana Jedlickova, Francis Ayuk, Robert Zeiser, Kerstin Schäfer-Eckart, Armin Gerbitz, Michael Stadler, Stefan Klein, Jan-Moritz Middeke, Anita Lawitschka, Julia Winkler, Jörg Halter, Ernst Holler, Guido Kobbe, Matthias Stelljes, Markus Ditschkowski, Hildegard Greinix |
| 264 | 1 | |c 2019 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 06.12.2019 | ||
| 520 | |a Chronic graft-versus-host disease (cGVHD) remains the leading cause of late morbidity and mortality. Despite the growing number of treatment options in cGVHD, evidence remains sparse. The German-Austrian-Swiss GVHD Consortium performed a survey on clinical practice in treatment of cGVHD among transplant centers in Germany, Austria, and Switzerland in 2009 and 2018 and compared the results. The survey performed in 2009 contained 20 questions on first-line treatment and related issues and 4 questions on second-line scenarios followed by a survey on all systemic and topic treatment options known and applied, with 31 of 36 transplant centers (86%) responding. The survey in 2018 repeated 7 questions on first-line treatment and 3 questions on second-line scenarios followed by an updated survey on all current systemic treatment options known and applied, with 29 of 66 centers (43%) responding. In summary, the results show a large overlap of first-line treatment practice between centers and the 2 surveys because of a lack of new data that changes practice, except significant heterogeneity of treatment of cGVHD progressive onset type, which can be explained by the lack of trials focusing on this high-risk entity. In contrast, treatment options applied to second-line therapy vary considerably, with new agents like ibrutinib and ruxolitinib entering clinical practice. Moreover, treatment of bronchiolitis obliterans syndrome demonstrates heterogeneity in applied therapeutic options and sequence because of a lack of controlled data and different conclusions from already existing evidence. In summary, the survey results demonstrate an increasing number of treatment options applied to cGVHD accompanied by a significant heterogeneity in second-line treatment and underline the urgent need for clinical trials and registry analyses on rare entities with high mortality like progressive onset type and lung involvement of cGVHD. | ||
| 650 | 4 | |a Allogeneic hematopoietic stem cell transplantation | |
| 650 | 4 | |a Bone marrow transplantation | |
| 650 | 4 | |a Chronic graft-versus-host disease | |
| 650 | 4 | |a Immunosuppressive therapy | |
| 700 | 1 | |a Hilgendorf, Inken |d 1974- |e VerfasserIn |0 (DE-588)123769884 |0 (DE-627)082756864 |0 (DE-576)293870411 |4 aut | |
| 700 | 1 | |a Wagner-Drouet, Eva |e VerfasserIn |0 (DE-588)1236647041 |0 (DE-627)1762310554 |4 aut | |
| 700 | 1 | |a Jedlickova, Zuzana |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ayuk, Francis |d 1973- |e VerfasserIn |0 (DE-588)1028065175 |0 (DE-627)730259161 |0 (DE-576)375553053 |4 aut | |
| 700 | 1 | |a Zeiser, Robert |d 1975- |e VerfasserIn |0 (DE-588)12346000X |0 (DE-627)082568081 |0 (DE-576)293718016 |4 aut | |
| 700 | 1 | |a Schäfer-Eckart, Kerstin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gerbitz, Armin |d 1968- |e VerfasserIn |0 (DE-588)115662138 |0 (DE-627)691490651 |0 (DE-576)290006163 |4 aut | |
| 700 | 1 | |a Stadler, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klein, Stefan |e VerfasserIn |0 (DE-588)1042491836 |0 (DE-627)769066372 |0 (DE-576)393988791 |4 aut | |
| 700 | 1 | |a Middeke, Jan Moritz |d 1980- |e VerfasserIn |0 (DE-588)1044764708 |0 (DE-627)77277319X |0 (DE-576)398114358 |4 aut | |
| 700 | 1 | |a Lawitschka, Anita |e VerfasserIn |4 aut | |
| 700 | 1 | |a Winkler, Julia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Halter, Jörg |e VerfasserIn |4 aut | |
| 700 | 1 | |a Holler, Ernst |e VerfasserIn |0 (DE-588)117672777X |0 (DE-627)1047753103 |0 (DE-576)516776398 |4 aut | |
| 700 | 1 | |a Kobbe, Guido |d 1967- |e VerfasserIn |0 (DE-588)122013174 |0 (DE-627)08168181X |0 (DE-576)293047596 |4 aut | |
| 700 | 1 | |a Stelljes, Matthias |d 1968- |e VerfasserIn |0 (DE-588)121680606 |0 (DE-627)705615030 |0 (DE-576)292826885 |4 aut | |
| 700 | 1 | |a Ditschkowski, Markus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Greinix, Hildegard |e VerfasserIn |0 (DE-588)1195457626 |0 (DE-627)1677496614 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biology of blood and marrow transplantation |d [Erscheinungsort nicht ermittelbar] : Elsevier Health Sciences, 1998 |g 25(2019), 7, Seite 1450-1455 |h Online-Ressource |w (DE-627)334374782 |w (DE-600)2057605-5 |w (DE-576)118352229 |x 1523-6536 |7 nnas |a Changes in immunosuppressive treatment of chronic graft-versus-host disease comparison of 2 surveys within allogeneic hematopoietic stem cell transplant centers in Germany, Austria, and Switzerland |
| 773 | 1 | 8 | |g volume:25 |g year:2019 |g number:7 |g pages:1450-1455 |g extent:6 |a Changes in immunosuppressive treatment of chronic graft-versus-host disease comparison of 2 surveys within allogeneic hematopoietic stem cell transplant centers in Germany, Austria, and Switzerland |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.bbmt.2019.03.003 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1083879119301545 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191206 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1042491836 |a Klein, Stefan |m 1042491836:Klein, Stefan |d 60000 |d 61200 |e 60000PK1042491836 |e 61200PK1042491836 |k 0/60000/ |k 1/60000/61200/ |p 10 | ||
| 999 | |a KXP-PPN1684667844 |e 3558328205 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"6 S."}],"person":[{"role":"aut","display":"Wolff, Daniel","family":"Wolff","given":"Daniel"},{"role":"aut","given":"Inken","family":"Hilgendorf","display":"Hilgendorf, Inken"},{"family":"Wagner-Drouet","display":"Wagner-Drouet, Eva","given":"Eva","role":"aut"},{"given":"Zuzana","family":"Jedlickova","display":"Jedlickova, Zuzana","role":"aut"},{"role":"aut","family":"Ayuk","display":"Ayuk, Francis","given":"Francis"},{"given":"Robert","display":"Zeiser, Robert","family":"Zeiser","role":"aut"},{"family":"Schäfer-Eckart","display":"Schäfer-Eckart, Kerstin","given":"Kerstin","role":"aut"},{"family":"Gerbitz","display":"Gerbitz, Armin","given":"Armin","role":"aut"},{"role":"aut","given":"Michael","family":"Stadler","display":"Stadler, Michael"},{"given":"Stefan","display":"Klein, Stefan","family":"Klein","role":"aut"},{"family":"Middeke","display":"Middeke, Jan Moritz","given":"Jan Moritz","role":"aut"},{"role":"aut","given":"Anita","display":"Lawitschka, Anita","family":"Lawitschka"},{"role":"aut","given":"Julia","display":"Winkler, Julia","family":"Winkler"},{"role":"aut","family":"Halter","display":"Halter, Jörg","given":"Jörg"},{"given":"Ernst","family":"Holler","display":"Holler, Ernst","role":"aut"},{"role":"aut","display":"Kobbe, Guido","family":"Kobbe","given":"Guido"},{"role":"aut","family":"Stelljes","display":"Stelljes, Matthias","given":"Matthias"},{"role":"aut","given":"Markus","display":"Ditschkowski, Markus","family":"Ditschkowski"},{"role":"aut","given":"Hildegard","display":"Greinix, Hildegard","family":"Greinix"}],"title":[{"subtitle":"comparison of 2 surveys within allogeneic hematopoietic stem cell transplant centers in Germany, Austria, and Switzerland","title":"Changes in immunosuppressive treatment of chronic graft-versus-host disease","title_sort":"Changes in immunosuppressive treatment of chronic graft-versus-host disease"}],"relHost":[{"recId":"334374782","pubHistory":["Volume 4, issue 1 (June 1998)-Volume 26, issue 12 (December 2020)"],"note":["Gesehen am 16.03.2021"],"disp":"Changes in immunosuppressive treatment of chronic graft-versus-host disease comparison of 2 surveys within allogeneic hematopoietic stem cell transplant centers in Germany, Austria, and SwitzerlandBiology of blood and marrow transplantation","titleAlt":[{"title":"BBMT"}],"title":[{"title":"Biology of blood and marrow transplantation","subtitle":"BBMT ; the official journal of the American Society for Blood and Marrow Transplantation","title_sort":"Biology of blood and marrow transplantation"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"25(2019), 7, Seite 1450-1455","pages":"1450-1455","volume":"25","issue":"7","extent":"6","year":"2019"},"origin":[{"dateIssuedDisp":"[1998-2020]","publisherPlace":"[Erscheinungsort nicht ermittelbar] ; Charlottesville, Va.","publisher":"Elsevier Health Sciences ; Carden Jennings"}],"language":["eng"],"id":{"eki":["334374782"],"issn":["1523-6536"],"zdb":["2057605-5"]},"type":{"media":"Online-Ressource","bibl":"periodical"}}],"id":{"eki":["1684667844"],"doi":["10.1016/j.bbmt.2019.03.003"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"origin":[{"dateIssuedDisp":"2019","dateIssuedKey":"2019"}],"name":{"displayForm":["Daniel Wolff, Inken Hilgendorf, Eva Wagner-Drouet, Zuzana Jedlickova, Francis Ayuk, Robert Zeiser, Kerstin Schäfer-Eckart, Armin Gerbitz, Michael Stadler, Stefan Klein, Jan-Moritz Middeke, Anita Lawitschka, Julia Winkler, Jörg Halter, Ernst Holler, Guido Kobbe, Matthias Stelljes, Markus Ditschkowski, Hildegard Greinix"]},"note":["Gesehen am 06.12.2019"],"recId":"1684667844"} | ||
| SRT | |a WOLFFDANIECHANGESINI2019 | ||